Lukasz Hudak

789 total citations
21 papers, 659 citations indexed

About

Lukasz Hudak is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lukasz Hudak has authored 21 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Lukasz Hudak's work include Histone Deacetylase Inhibitors Research (12 papers), Prostate Cancer Treatment and Research (8 papers) and Protein Degradation and Inhibitors (7 papers). Lukasz Hudak is often cited by papers focused on Histone Deacetylase Inhibitors Research (12 papers), Prostate Cancer Treatment and Research (8 papers) and Protein Degradation and Inhibitors (7 papers). Lukasz Hudak collaborates with scholars based in Germany, United States and Netherlands. Lukasz Hudak's co-authors include Roman A. Blaheta, Eva Juengel, Steffen Wedel, Axel Haferkamp, Dietger Jonas, Christoph Wiesner, Liudmila Leppik, Dirk Henrich, John H. Barker and Igor Tsaur and has published in prestigious journals such as Scientific Reports, Life Sciences and Cancer Letters.

In The Last Decade

Lukasz Hudak

21 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukasz Hudak Germany 16 475 146 130 78 65 21 659
Lois E. H. Smith United States 6 300 0.6× 124 0.8× 52 0.4× 69 0.9× 26 0.4× 7 631
Silin Sa United States 11 330 0.7× 118 0.8× 221 1.7× 57 0.7× 22 0.3× 13 615
Suzan Ruijtenberg Netherlands 9 412 0.9× 89 0.6× 41 0.3× 70 0.9× 27 0.4× 11 662
Antonio Fernandez-Perez United States 13 623 1.3× 152 1.0× 50 0.4× 148 1.9× 62 1.0× 23 908
Zhijian Cheng China 16 314 0.7× 92 0.6× 86 0.7× 49 0.6× 176 2.7× 29 799
Leelamma M. Panicker United States 13 378 0.8× 110 0.8× 42 0.3× 73 0.9× 67 1.0× 17 839
Montserrat Lara‐Velazquez United States 14 253 0.5× 134 0.9× 81 0.6× 88 1.1× 32 0.5× 28 657
Ryoichi Aki Japan 17 278 0.6× 125 0.9× 53 0.4× 57 0.7× 190 2.9× 34 639
Rupavathana Mahesparan Norway 14 414 0.9× 148 1.0× 42 0.3× 164 2.1× 70 1.1× 33 1.1k
Abdullah Alajati Germany 10 366 0.8× 117 0.8× 69 0.5× 168 2.2× 26 0.4× 17 595

Countries citing papers authored by Lukasz Hudak

Since Specialization
Citations

This map shows the geographic impact of Lukasz Hudak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukasz Hudak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukasz Hudak more than expected).

Fields of papers citing papers by Lukasz Hudak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukasz Hudak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukasz Hudak. The network helps show where Lukasz Hudak may publish in the future.

Co-authorship network of co-authors of Lukasz Hudak

This figure shows the co-authorship network connecting the top 25 collaborators of Lukasz Hudak. A scholar is included among the top collaborators of Lukasz Hudak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukasz Hudak. Lukasz Hudak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leppik, Liudmila, Zhihua Han, Sahba Mobini, et al.. (2018). Combining electrical stimulation and tissue engineering to treat large bone defects in a rat model. Scientific Reports. 8(1). 6307–6307. 150 indexed citations
2.
Leppik, Liudmila, Dara Froemel, Lukasz Hudak, et al.. (2015). Effects of electrical stimulation on rat limb regeneration, a new look at an old model. Scientific Reports. 5(1). 18353–18353. 59 indexed citations
3.
Tsaur, Igor, Lukasz Hudak, Jasmina Makarević, et al.. (2015). Intensified antineoplastic effect by combining an HDAC‐inhibitor, an mTOR‐inhibitor and low dosed interferon alpha in prostate cancer cells. Journal of Cellular and Molecular Medicine. 19(8). 1795–1804. 11 indexed citations
4.
Juengel, Eva, Sascha Meyer dos Santos, Tanja Schneider, et al.. (2013). HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions. Experimental Biology and Medicine. 238(11). 1297–1304. 18 indexed citations
5.
Hudak, Lukasz, Steffen Wedel, Jasmina Makarević, et al.. (2012). Low dosed interferon alpha augments the anti‐tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion. The Prostate. 72(16). 1719–1735. 21 indexed citations
6.
Tsaur, Igor, Jasmina Makarević, Lukasz Hudak, et al.. (2011). The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line. Cancer Letters. 313(1). 84–90. 44 indexed citations
7.
Wedel, Steffen, Lukasz Hudak, Jasmina Makarević, et al.. (2011). Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells. Clinical & Experimental Metastasis. 28(5). 479–491. 47 indexed citations
8.
9.
Vallo, Stefan, Xi Wang, Lukasz Hudak, et al.. (2011). HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro. Anti-Cancer Drugs. 22(10). 1002–1009. 26 indexed citations
10.
11.
Hudak, Lukasz, et al.. (2010). The Intraflagellar Transport Protein Ift80 Is Essential for Photoreceptor Survival in a Zebrafish Model of Jeune Asphyxiating Thoracic Dystrophy. Investigative Ophthalmology & Visual Science. 51(7). 3792–3799. 34 indexed citations
12.
Wedel, Steffen, Lukasz Hudak, Eva Juengel, et al.. (2010). Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer. The Prostate. 71(7). 722–735. 11 indexed citations
13.
Wedel, Steffen, Lukasz Hudak, Eva Juengel, et al.. (2010). Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001. Life Sciences. 88(9-10). 418–424. 31 indexed citations
14.
15.
16.
Blaheta, Roman A., Maciej Powerski, Lukasz Hudak, et al.. (2009). Tumor-Endothelium Cross Talk Blocks Recruitment of Neutrophils to Endothelial Cells: A Novel Mechanism of Endothelial Cell Anergy. Neoplasia. 11(10). 1054–1063. 15 indexed citations
17.
Wedel, Steffen, Eva Juengel, Janice Jones, et al.. (2008). Präklinische Studien zum Einfluss des Tyrosinkinaseinhibitors AEE788 auf die Malignität des Nierenzellkarzinoms. Der Urologe. 47(9). 1175–1181. 2 indexed citations
18.
Jones, Jon, Eva Juengel, Lukasz Hudak, et al.. (2008). The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo. Journal of Cellular and Molecular Medicine. 13(8b). 2376–2385. 52 indexed citations
19.
Jones, Jon, Eva Juengel, Lukasz Hudak, et al.. (2008). Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix. Journal of Cellular and Molecular Medicine. 13(8b). 2342–2352. 15 indexed citations
20.
Wedel, Steffen, Anna Sparatore, Piero Del Soldato, et al.. (2008). New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma. Journal of Cellular and Molecular Medicine. 12(6a). 2457–2466. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lois E. H. Smith Breakdown of academic impact, for papers by Silin Sa Breakdown of academic impact, for papers by Suzan Ruijtenberg Breakdown of academic impact, for papers by Antonio Fernandez-Perez Breakdown of academic impact, for papers by Zhijian Cheng Breakdown of academic impact, for papers by Leelamma M. Panicker Breakdown of academic impact, for papers by Montserrat Lara‐Velazquez Breakdown of academic impact, for papers by Ryoichi Aki Breakdown of academic impact, for papers by Rupavathana Mahesparan Breakdown of academic impact, for papers by Abdullah Alajati
Rankless by CCL
2026